Skip to content

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses.

Philip E. Wolfson, Julane Andries, Daniel Ahlers, Melissa Whippo

Frontiers in Psychiatry 2023 DOI: 10.3389/fpsyt.2023.1141988 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case series Case report Peer reviewed
Sample size 4
Population Adolescents aged 14–19 with comorbid psychiatric diagnoses including treatment-resistant depression, bipolar disorder, eating disorders, anxiety, panic, and trauma-related symptoms
Interventions Ketamine-assisted psychotherapy sublingual ketamine intramuscular ketamine
Topics Depression Ketamine Esketamine Psychedelic-assisted therapy
Keywords Adolescent psychiatry Bipolar disorder Eating disorders Ketamine-assisted psychotherapy Psychedelic psychotherapy
Citations 27
Key findings Ketamine-assisted psychotherapy was associated with symptomatic and functional improvements and was well-tolerated in four adolescents with complex, treatment-resistant mental disorders.

Abstract

Ketamine-assisted psychotherapy is a promising new treatment for a variety of mental disorders of adolescence. There is currently an adolescent mental health crisis, with a high prevalence of disorders, diagnostic complexity, and many adolescents failing to respond to conventional treatments. While there is strong evidence for the use of ketamine in adults for a variety of treatment-refractory mental illnesses, research in adolescents is in its early stages. Ketamine-assisted psychotherapy (KAP) has been described in adults with promising results and here we present the first published cases of the use of KAP in adolescents. The four cases include adolescents aged 14-19 at the initiation of treatment, each with a variety of comorbid diagnoses including treatment-resistant depression, bipolar disorder, eating disorders, anxiety, panic, and trauma-related symptoms. They each initially received sublingual ketamine, followed by sessions with intramuscular ketamine. Their courses varied, but each had symptomatic and functional improvements, and the treatment was well-tolerated. Subjective patient reports are included. Rapid resolution of symptomatology and suffering often occurs within months as the result of the application of KAP to adolescent psychiatric care but is not inevitable. Family involvement in the treatment process appears to be essential to success. The development of this modality may have a singularly positive impact that will expand the psychiatric toolbox and its healing potency.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

Comparable studies

Other case reports and case series on ketamine and psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy. A 29-year-old man with bipolar disorder, Autism Spectrum Disorder, and type 2 diabetes 2024 Case study n = 1
Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa. Female patient in her late twenties with anorexia nervosa and comorbid depression 2025 Case report n = 1
Ketamine-Assisted Psychotherapy for Treatment of Co-occurring Borderline Personality Disorder and Depression: A Case Study. A patient with co-occurring borderline personality disorder and depression 2025 Case study n = 1
Qualitative analysis of a patient's experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs 28-year-old female treated for alcohol and opioid use disorder 2025 Case study n = 1
Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report. 43-year-old man with antisocial personality disorder, alcoholism, and depression 2025 Case report n = 1

Explore topics

By condition and practice